Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2013-05, Vol.57 (5), p.2388-2390 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2390 |
---|---|
container_issue | 5 |
container_start_page | 2388 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 57 |
creator | GIAMARELLOU, Helen GALANI, Lambrini BAZIAKA, Fotini KARAISKOS, Ilias |
description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/AAC.02399-12 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1128_AAC_02399_12</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1326728060</sourcerecordid><originalsourceid>FETCH-LOGICAL-a507t-36f42ab114da6d7ec856c06c143ea0d933458576956c0a9a72e50c13dd50b9b3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEosvCjTMyBySQSLHj2IkvSKttoRWVqKrerYkzybpK7MVOingHHhpvd2nhgDjZHn_ze2Z-Z9lLRo8ZK-oPq9X6mBZcqZwVj7IFo6rOpVDycbagVMq8rGl5lD2L8Yams1D0aXZU8JIrycUi-3nadWgme4sOYyS-I0BO_NwMmK8hNLBN8ZFcYW9HdKTzgZy7uwTvIrGOnM0jpN3JjGTy5CEFIuaXwbezsa4nl-DaMPf5FUYbJ3AT-TJgEy0OA5Ctw3n0zgI-z550MER8cViX2fWn0-v1WX7x9fP5enWRg6DVlHPZlQU0jJUtyLZCUwtpqDSs5Ai0VZyXohaVVLswKKgKFNQw3raCNqrhy-zjXnY7NyO2Bt0UYNDbYEcIP7QHq_--cXaje3-rueSFSrNeZm8PAsF_mzFOerTR7Jpx6OeoWckUlzWtxP9RXsiqqKmkCX2_R03wMQbs7itiVO-s1slqfWe1Zrsi3u1xiGOhb_wcXJrZv9hXf3Z8L_z7HyTgzQGAaGDoAjhj4wNXFZUQVZW413tuY_vNdxtQp9c1gNGi0iLp1TX_BS6yysc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1326728060</pqid></control><display><type>article</type><title>Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>GIAMARELLOU, Helen ; GALANI, Lambrini ; BAZIAKA, Fotini ; KARAISKOS, Ilias</creator><creatorcontrib>GIAMARELLOU, Helen ; GALANI, Lambrini ; BAZIAKA, Fotini ; KARAISKOS, Ilias</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.02399-12</identifier><identifier>PMID: 23439635</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adult ; Anti-Bacterial Agents ; Anti-Bacterial Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteremia ; Bacteremia - drug therapy ; Bacteremia - microbiology ; Bacterial Proteins - antagonists & inhibitors ; beta-Lactamase Inhibitors ; beta-Lactamases ; beta-Lactams ; beta-Lactams - pharmacology ; Biological and medical sciences ; Carbapenems ; Carbapenems - pharmacology ; Clinical Therapeutics ; Drug Combinations ; Drug Resistance, Bacterial - drug effects ; Female ; Humans ; Klebsiella Infections ; Klebsiella Infections - drug therapy ; Klebsiella Infections - microbiology ; Klebsiella pneumoniae ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - enzymology ; Klebsiella pneumoniae - growth & development ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Thienamycins ; Thienamycins - pharmacology ; Treatment Outcome ; Urinary Tract Infections ; Urinary Tract Infections - drug therapy ; Urinary Tract Infections - microbiology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2388-2390</ispartof><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2013, American Society for Microbiology. All Rights Reserved. 2013 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a507t-36f42ab114da6d7ec856c06c143ea0d933458576956c0a9a72e50c13dd50b9b3</citedby><cites>FETCH-LOGICAL-a507t-36f42ab114da6d7ec856c06c143ea0d933458576956c0a9a72e50c13dd50b9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632902/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632902/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27275577$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23439635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GIAMARELLOU, Helen</creatorcontrib><creatorcontrib>GALANI, Lambrini</creatorcontrib><creatorcontrib>BAZIAKA, Fotini</creatorcontrib><creatorcontrib>KARAISKOS, Ilias</creatorcontrib><title>Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Adult</subject><subject>Anti-Bacterial Agents</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteremia</subject><subject>Bacteremia - drug therapy</subject><subject>Bacteremia - microbiology</subject><subject>Bacterial Proteins - antagonists & inhibitors</subject><subject>beta-Lactamase Inhibitors</subject><subject>beta-Lactamases</subject><subject>beta-Lactams</subject><subject>beta-Lactams - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Carbapenems</subject><subject>Carbapenems - pharmacology</subject><subject>Clinical Therapeutics</subject><subject>Drug Combinations</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Female</subject><subject>Humans</subject><subject>Klebsiella Infections</subject><subject>Klebsiella Infections - drug therapy</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - enzymology</subject><subject>Klebsiella pneumoniae - growth & development</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Thienamycins</subject><subject>Thienamycins - pharmacology</subject><subject>Treatment Outcome</subject><subject>Urinary Tract Infections</subject><subject>Urinary Tract Infections - drug therapy</subject><subject>Urinary Tract Infections - microbiology</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksFu1DAQhiMEosvCjTMyBySQSLHj2IkvSKttoRWVqKrerYkzybpK7MVOingHHhpvd2nhgDjZHn_ze2Z-Z9lLRo8ZK-oPq9X6mBZcqZwVj7IFo6rOpVDycbagVMq8rGl5lD2L8Yams1D0aXZU8JIrycUi-3nadWgme4sOYyS-I0BO_NwMmK8hNLBN8ZFcYW9HdKTzgZy7uwTvIrGOnM0jpN3JjGTy5CEFIuaXwbezsa4nl-DaMPf5FUYbJ3AT-TJgEy0OA5Ctw3n0zgI-z550MER8cViX2fWn0-v1WX7x9fP5enWRg6DVlHPZlQU0jJUtyLZCUwtpqDSs5Ai0VZyXohaVVLswKKgKFNQw3raCNqrhy-zjXnY7NyO2Bt0UYNDbYEcIP7QHq_--cXaje3-rueSFSrNeZm8PAsF_mzFOerTR7Jpx6OeoWckUlzWtxP9RXsiqqKmkCX2_R03wMQbs7itiVO-s1slqfWe1Zrsi3u1xiGOhb_wcXJrZv9hXf3Z8L_z7HyTgzQGAaGDoAjhj4wNXFZUQVZW413tuY_vNdxtQp9c1gNGi0iLp1TX_BS6yysc</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>GIAMARELLOU, Helen</creator><creator>GALANI, Lambrini</creator><creator>BAZIAKA, Fotini</creator><creator>KARAISKOS, Ilias</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20130501</creationdate><title>Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae</title><author>GIAMARELLOU, Helen ; GALANI, Lambrini ; BAZIAKA, Fotini ; KARAISKOS, Ilias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a507t-36f42ab114da6d7ec856c06c143ea0d933458576956c0a9a72e50c13dd50b9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteremia</topic><topic>Bacteremia - drug therapy</topic><topic>Bacteremia - microbiology</topic><topic>Bacterial Proteins - antagonists & inhibitors</topic><topic>beta-Lactamase Inhibitors</topic><topic>beta-Lactamases</topic><topic>beta-Lactams</topic><topic>beta-Lactams - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Carbapenems</topic><topic>Carbapenems - pharmacology</topic><topic>Clinical Therapeutics</topic><topic>Drug Combinations</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Female</topic><topic>Humans</topic><topic>Klebsiella Infections</topic><topic>Klebsiella Infections - drug therapy</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - enzymology</topic><topic>Klebsiella pneumoniae - growth & development</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Thienamycins</topic><topic>Thienamycins - pharmacology</topic><topic>Treatment Outcome</topic><topic>Urinary Tract Infections</topic><topic>Urinary Tract Infections - drug therapy</topic><topic>Urinary Tract Infections - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GIAMARELLOU, Helen</creatorcontrib><creatorcontrib>GALANI, Lambrini</creatorcontrib><creatorcontrib>BAZIAKA, Fotini</creatorcontrib><creatorcontrib>KARAISKOS, Ilias</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GIAMARELLOU, Helen</au><au>GALANI, Lambrini</au><au>BAZIAKA, Fotini</au><au>KARAISKOS, Ilias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>57</volume><issue>5</issue><spage>2388</spage><epage>2390</epage><pages>2388-2390</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>23439635</pmid><doi>10.1128/AAC.02399-12</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2388-2390 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_crossref_primary_10_1128_AAC_02399_12 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Adult Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteremia Bacteremia - drug therapy Bacteremia - microbiology Bacterial Proteins - antagonists & inhibitors beta-Lactamase Inhibitors beta-Lactamases beta-Lactams beta-Lactams - pharmacology Biological and medical sciences Carbapenems Carbapenems - pharmacology Clinical Therapeutics Drug Combinations Drug Resistance, Bacterial - drug effects Female Humans Klebsiella Infections Klebsiella Infections - drug therapy Klebsiella Infections - microbiology Klebsiella pneumoniae Klebsiella pneumoniae - drug effects Klebsiella pneumoniae - enzymology Klebsiella pneumoniae - growth & development Male Medical sciences Middle Aged Pharmacology. Drug treatments Thienamycins Thienamycins - pharmacology Treatment Outcome Urinary Tract Infections Urinary Tract Infections - drug therapy Urinary Tract Infections - microbiology |
title | Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T17%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20a%20Double-Carbapenem%20Regimen%20for%20Infections%20in%20Humans%20Due%20to%20Carbapenemase-Producing%20Pandrug-Resistant%20Klebsiella%20pneumoniae&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=GIAMARELLOU,%20Helen&rft.date=2013-05-01&rft.volume=57&rft.issue=5&rft.spage=2388&rft.epage=2390&rft.pages=2388-2390&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.02399-12&rft_dat=%3Cproquest_cross%3E1326728060%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1326728060&rft_id=info:pmid/23439635&rfr_iscdi=true |